Sri Ambikare Pharma Private Limited, a active private limited company, was established on 06 November 2007 in Mahbubnagar, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232TG2007PTC056228. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹16.00 Cr and a paid-up capital of ₹3.00 Cr.
Formerly known as Leesa Lifesciences Private Limited. It upholds a compliant status. Its leadership includes Kasthur Reddy Nemallapudi (Director), Ramadevi Nemallapudi (Director). Past directors included Grandhi Venkata Rao, Naveen Kumar Naraharisetty, Venkata Varaprasad Rao Gupta Kothuri. It holds no open charges and ₹21.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at P2,Sy.No.423(P) 424(P) And 425(P), Jedcherla Mandal, Polepally, Mahbubnagar, Telangana, 509203.
U24232TG2007PTC056228
056228
06 November 2007
₹16.00 Cr
₹3.00 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Sri Ambikare Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kasthur Reddy Nemallapudi | Director | 18 Oct 2022 | Current |
| Ramadevi Nemallapudi | Director | 18 Oct 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 16 Jul 2011 | Past |
| Pramod Abcsdd | Additional Director | 03 Mar 2012 | Past |
| Pramod Abcsdd | Director | 18 Oct 2022 | Past |
| Pramod Abcsdd | Director | 10 Jul 2008 | Past |
| Pramod Abcsdd | Director | 30 Sep 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Leesa Lifesciences Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 189.22% increase. The company also saw a substantial improvement in profitability, with a 69.69% increase in profit. The company's net worth dipped by a decrease of 0.18%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Sri Ambikare Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹215,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Dec 2009 | State Bank Of India | ₹21.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Sri Ambikare Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sri Ambikare Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Ambikare Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sri Ambikare Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Sri Ambikare Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
A charge registered on 08 Dec 2009 via Charge ID 10188705 with State Bank Of India was fully satisfied on 06 Jan 2023. was recorded as a recent event.
Kasthur Reddy Nemallapudi was appointed as a Director was appointed as a Director on 18 Oct 2022 & has been associated with this company since 3 years 1 month . was recorded as a recent event.
Progress on Ramadevi Nemallapudi was appointed as a Director was appointed as a Director on 18 Oct 2022 & has been associated with this company since 3 years 1 month . was documented.
A charge with State Bank Of India of Rs. 21.50 Cr registered on 08 Dec 2009 with Charge ID 10188705 was modified on 28 Sep 2011. was recorded as a recent event.
The CIN of Sri Ambikare Pharma Private Limited is U24232TG2007PTC056228.
Sri Ambikare Pharma Private Limited is headquartered at P2,Sy.No.423(P) 424(P) And 425(P), Jedcherla Mandal, Polepally, Mahbubnagar, Telangana, 509203.
Sri Ambikare Pharma Private Limited was incorporated on 06 November 2007.
The current directors of Sri Ambikare Pharma Private Limited are
The primary industry of Sri Ambikare Pharma Private Limited is Manufacturing.
Sri Ambikare Pharma Private Limited is unlisted.
The authorized capital of Sri Ambikare Pharma Private Limited is ₹16.00 Cr, and the paid-up capital is ₹3.00 Cr.
The compliance status of Sri Ambikare Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX